Physician profile
Patrick Wong
NPI 1740445279
$1,511.79
in general payments reported to CMS, 2019-2025
18 companies · $556 in 2025
The $556 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $18.41 · 2021: $28.41 · 2022: $400 · 2023: $112 · 2024: $275 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $331.74 | 2025 | Indigo System |
| Abbott Laboratories | $242.28 | 2024-2025 | 2nd Gen Centrimag Primary Console, Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $211.78 | 2021-2024 | Eliquis |
| Abiomed | $182.77 | 2023-2025 | Impella |
| Organogenesis INC. | $120.03 | 2022 | |
| Novartis Pharmaceuticals Corporation | $73.57 | 2019-2022 | |
| Ucb, INC. | $57.66 | 2019-2022 | |
| Inari Medical, INC. | $48.95 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $42.04 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.70 | 2024 | Lifevest |
| Merck Sharp & Dohme LLC | $31.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.70 | 2024 | Jardiance |
| Boston Scientific Corporation | $24.01 | 2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals Lp | $18.41 | 2020 | |
| Novo Nordisk INC | $17.39 | 2025 | Ozempic, Rybelsus |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.95 | 2022 | |
| Xeris Pharmaceuticals, INC. | $12.13 | 2022 | |
| Paratek Pharmaceuticals, INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.